Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT)
conducted a revision of the 2009 guidelines by updating the evidence and …

Repetitive Transcranial Magnetic Stimulation (rTMS) has been approved by the FDA as an
effective intervention for Treatment-Resistant Depression (TRD). However, there is little …

Major depression is often difficult to diagnose accurately. Even when the diagnosis is
properly made, standard treatment approaches (eg, psychotherapy, medications, or their …

Background The therapeutic options for treatment-resistant depression (TRD) encompass a
range of neuromodulatory techniques, including repetitive transcranial magnetic stimulation …

Depression is a common mental disorder, which attributes to significant morbidity, disability
and burden of care. A significant number of patients with depression still remain …

Noninvasive brain stimulation refers to a set of technologies and techniques with which to
modulate the excitability of the brain via transcranial stimulation. Two major modalities of …

With the ability to modulate cortical activity, repetitive transcranial magnetic stimulation
(rTMS) is becoming increasingly important in clinical applications for psychiatric disorders …

Background A dearth of evidence-based information exists to guide the delivery of
transcranial magnetic stimulation (TMS) after a successful acute course of treatment for …

Background Repetitive transcranial magnetic stimulation (TMS) is efficacious for acute
treatment of resistant major depressive disorder (MDD), but there is little information on …

Major depressive disorder is a highly prevalent condition with significant morbidity and
mortality. Recurrent episodes occur in greater than 50% of patients within a one year period …